Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Immunotherapy|November 17, 2021
Immunomodulation with β-glucan from <i>Pleurotus ostreatus</i> in patients with endocrine-dependent breast cancerJan Spacek, Michal Vocka, Eva Zavadova, et al.Astrobiology|December 30, 2025
Viking Mars, Now 50 Years Old, Still Needs a Scientific AnalysisSteven A Benner, Dirk Schulze-Makuch, Jan Spacek, et al.Immunological Investigations|June 21, 2018
Immunological examination of peripheral blood in patients with colorectal cancer compared to healthy controlsJan Spacek, Michal Vocka, Irena Netikova, et al.Journal of Cancer Research and Clinical Oncology|February 22, 2024
Immunophenotyping of peripheral blood in NSCLC patients discriminates responders to immune checkpoint inhibitorsLudmila Krizova, Iva Benesova, Petra Zemanova, et al.Journal of Cancer|July 31, 2025
Pembrolizumab versus Pembrolizumab plus Chemotherapy in Non-small Cell Lung Cancer with High PD-L1 Expression - Multicenter Real-world Evidence StudyMartin Svaton, Magdalena Knetki-Wroblewska, Petr Hosek, et al.Medrxiv : the Preprint Server for Health Sciences|October 27, 2021
A Thermostable Cas12b from <i>Brevibacillus</i> Leverages One-pot Detection of SARS-CoV-2 Variants of ConcernLong T Nguyen, Nicolas C Macaluso, Brianna L M Pizzano, et al.Ebiomedicine|March 15, 2022
A thermostable Cas12b from Brevibacillus leverages one-pot discrimination of SARS-CoV-2 variants of concernLong T Nguyen, Nicolas C Macaluso, Brianna L M Pizzano, et al.Therapeutic Advances in Medical Oncology|October 3, 2023
Mitochondrially targeted tamoxifen as anticancer therapy: case series of patients with renal cell carcinoma treated in a phase I/Ib clinical trialZuzana Bielcikova, Lukas Werner, Jan Stursa, et al.Eclinicalmedicine|April 17, 2023
Mitochondrially targeted tamoxifen in patients with metastatic solid tumours: an open-label, phase I/Ib single-centre trialZuzana Bielcikova, Jan Stursa, Ludmila Krizova, et al.Cancers|January 21, 2023
Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon CancerBernhard Mlecnik, Alessandro Lugli, Gabriela Bindea, et al.Pageof 2